Obalon Therapeutics Inc  (OBLN) - NASDAQGM

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2019
(Fiscal Year)
2018
(Fiscal Year)
2017
(Fiscal Year)
March      
   Revenue $1,775(t) $1,346(t) $1,472(t)
   EPS -3.6 (3/31/2019) -7.1 (3/31/2018) -4.7 (3/31/2017)
   Dividends N/A N/A N/A
June      
   Revenue $386,000 $2,732(t) $1,963(t)
   EPS -2.4 (6/30/2019) -5.8 (6/30/2018) -4.6 (6/30/2017)
   Dividends N/A N/A N/A
September      
   Revenue   $2,987(t) $2,787(t)
   EPS   -3.1 (9/30/2018) -5.5 (9/30/2017)
   Dividends   N/A N/A
December  (FYE)      
   Revenue   $2,036(t) $3,692(t)
   EPS   -3.6 (12/31/2018) -6 (12/31/2017)
   Dividends   N/A N/A
Totals      
   Revenue $2,161(t) $9,101(t) $9,914(t)
   EPS -6 -19.6 -20.8
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2019, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.